Oxford Gene Technology Grants Microarray Licence to BF-BIOlabs
News Sep 29, 2008
Oxford Gene Technology (OGT) and BF-BIOlabs have announced the completion of a licensing agreement granting BF-BIOlabs access to OGT’s “Southern array patents”, the fundamental patents covering the manufacture and marketing of oligonucleotide microarrays.
The granted licence will enable BF-BIOlabs to sell arrays and provide services that include the design and production of custom-made microarrays for gene-identification, single nucleotide polymorphisms (SNP) and gene expression analysis.
Susan Sutton, Vice President Licensing (North America and Europe) at OGT, said: “OGT continues to grow its microarray licensee portfolio in Europe and this in turn will enable companies to expand their business activities and make microarray technology more accessible.”
BF-BIOlabs designs and produces custom-made microarrays for gene-identification, SNP, and gene-expression analysis, using specialized microarray production processes to achieve optimal specificity and sensitivity. In addition, BF-BIOlabs offers a full service for microarray experiments, chip readout and data analysis.
The licence will remain valid for the patents’ lifetime. Financial details were not disclosed.
2nd International Conference on Pharmaceutical Research & Innovations in Pharma Industry
May 30 - May 31, 2019